Effect of Integrated Neuromuscular Inhibition Technique in Females With Menstrual Low Back Pain

Dysmenorrhea Clinical Trial

Official title:

Effect of Integrated Neuromuscular Inhibition Technique on Pain, Function and Muscle Activity in Females With Menstrual Low Back Pain

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05461846
• Other study ID #: p.T.RCE/012/003493
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 1, 2022
• Est. completion date: June 1, 2023

Study information

• Verified date: July 2022
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Dysmenorrhea is a common problem in women of reproductive age. Primary dysmenorrhea is defined as recurrent, cramping pain occurring with menses in the absence of identifiable pelvic pathology .

Description:

Primary dysmenorrhea is characterized by a crampy supra-pubic pain that begins somewhere between several hours before and a few hours after the onset of the menstrual bleeding. Symptoms peak with maximum blood flow and usually last less than one day, but the pain may persist up to 2 to 3 days. Symptoms are more or less reproducible from one menstrual period to the other. The pain is characteristically colicky and located in the midline of the lower abdomen and may extend to lower quadrants, the lumbar area, and the thighs. Menstrual low back pain (LBP) is one of the common complaints among women. Previous studies have indicated that more than 40% to 50% of the population experience LBP during the menstrual phase (days 1-6) of the menstrual cycle .

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: June 1, 2023
• Est. primary completion date: April 1, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 17 Years to 24 Years

Eligibility

Inclusion Criteria:

1. Thirty adolescent females suffering from menstrual low back pain.

2. Their age will be ranged from 17 to 24 years.

3. Their body mass index will be ranged from 20 to 25 kg/m2.

Exclusion Criteria:

1. Personal and individual differences between the subjects.

2. Psychological and physical status of subjects which may affect the treatment and evaluation stage.

3. Environmental factors which may affect the subject's response

Related Conditions & MeSH terms

• Back Pain
• Dysmenorrhea
• Low Back Pain

Intervention

Other:
• integrated neuromuscular inhibition technique
is a manual deactivation trigger points technique and includes the application of ischemic pressure and stretch, the muscle energy technique and the Strain-counterstrain technique.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain intensity	The pain intensity will be assessed through visual analogue scale (VAS) for both groups before and after the end of treatment program. Each woman will be asked to mark a point on the line between the extremes that related to her pain intensity.	up to 2 months
Secondary	function	Oswestery Disability Index will be used to assess level of functional disability for both groups before and at the end of the study	up to 2 months
Secondary	muscle amplitude in the form of normalized root mean square (RMS)	muscle amplitude will be measured by surface electromyography for upper trapezius	up to 2 months